フェキソフェナジン塩酸塩60 mg/フェニレフリン塩酸塩10 mg 配合剤(FEX60/PE10 錠)のアレルギー性鼻炎患者に対する有効性および安全性の検討―多施設共同,オープンラベル試験―

作者
高原宣仁
出处
期刊:Therapeutic research [Life Science Publishing Co. Ltd.]
卷期号:38 (5): 505-517
摘要

Background:Treatment with histamine H1 receptor agonists tends to be less effective for nasal congestion than for the other two primary symptoms of allergic rhinitis (repeated sneezing and rhinorrhea). We thus explored the efficacy and safety of a fixed dose combination(FDC)of 60 mg fexofenadine hydrochloride(FEX), a second‒generation antihistamine known for its good safety profile, and 10 mg phenylephrine(PE), an α1 receptor agonist effective against nasal congestion. Methods:A multicenter open‒label study comparing the effectiveness before and after 2‒week twice‒daily administration of oral FEX60/PE10 FDC tablets for at least 1 year in patients aged 15 years and older with allergic rhinitis. The primary endpoint was mean change from baseline in nasal congestion score. The secondary endpoints were mean change from baseline in daily, daytime, and nighttime scores for the following:combined scores for sneezing, rhinorrhea, and nasal congestion;individual scores for sneezing, rhinorrhea, and impact on daily activities;change in nasal cavity findings;patient impressions;and change in symptom severity. Results:This 3‒center study was conducted from March to July 2015 in Japan. The intent‒to‒treat population was 105 patients with a mean age of 38.9 years;all were included in safety analysis and in the modified intent‒to‒treat group. Slightly more subjects were male(56 subjects, 53.3%). The allergy diagnosis was seasonal allergic rhinitis in 48 subjects(45.7%), perennial allergic rhinitis in 25 (23.8%), and mixed allergic rhinitis in 32(30.5%). Mean improvement in nasal congestion score was statistically significant(-0.798;95%CI -0.91 to -0.68;p<0.001). Secondary endpoints also improved significantly. Patient impressions were favorable, and physician assessment tended toward improvement for all symptoms. Adverse events were noted in 7 patients (6.67%);the most common was rhinopharyngitis in 4 patients(3.81%). Adverse drug reactions were 1 case of aggravated preexisting hepatic steatosis and 1 case of somnolence(0.95% each). The hepatic steatosis was confirmed to have been relieved, and the other adverse events were confirmed resolved. No serious adverse events were reported. Conclusion:FEX60/PE10 tablets were effective against nasal congestion, and also improved other rhinitis symptoms and reduced the impact of those symptoms on daily activities. The drug was generally well‒tolerated.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潇洒书易发布了新的文献求助10
1秒前
HanQing完成签到,获得积分10
1秒前
2秒前
2秒前
qearl发布了新的文献求助10
2秒前
Mi完成签到,获得积分10
2秒前
2秒前
单纯草丛完成签到,获得积分10
3秒前
3秒前
3秒前
贪玩的水壶完成签到 ,获得积分10
3秒前
派大星完成签到,获得积分10
3秒前
KIC完成签到,获得积分10
3秒前
酷波er的应助被大力荷花采纳,获得10
3秒前
小阿志完成签到,获得积分10
3秒前
4秒前
完美世界的应助被醉熏的代秋采纳,获得10
4秒前
bz完成签到,获得积分10
4秒前
谨慎初曼完成签到,获得积分10
4秒前
回星予你发布了新的文献求助10
4秒前
5秒前
5秒前
YXL完成签到,获得积分10
5秒前
漂亮的战斗机完成签到 ,获得积分10
5秒前
guoguo发布了新的文献求助10
6秒前
Emma施施完成签到,获得积分10
6秒前
爱撒娇的天磊完成签到,获得积分10
6秒前
6秒前
王哇噻完成签到 ,获得积分10
6秒前
秋风的应助被jinx采纳,获得20
6秒前
Jasper的应助被科研通管家采纳,获得10
6秒前
小二郎的应助被科研通管家采纳,获得10
6秒前
hxhdh的应助被科研通管家采纳,获得20
6秒前
6秒前
6秒前
今后的应助被悦耳十三采纳,获得10
6秒前
Akim的应助被科研通管家采纳,获得10
6秒前
专注的网络完成签到 ,获得积分10
6秒前
SAKURA的应助被科研通管家采纳,获得10
6秒前
充电宝的应助被科研通管家采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091